Clinical Trial Update: Optimal Transfusion in Anaemic Cancer Patients Treated With Chemotherapy (HaemOPtimal) [Phase 2]

View source ↗

Summary

HaemOPtimal is a Phase 2 trial assessing optimal transfusion strategies for anaemic cancer patients undergoing chemotherapy; the study has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Cancer

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Cancer, Anaemia | Phase 2 | Status: TERMINATED